Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Inspire Medical Systems, Inc.

Capitalization 1.8B 1.55B 1.4B 1.34B 2.45B 165B 2.57B 16.57B 6.64B 79.36B 6.76B 6.61B 284B P/E ratio 2026 *
39.7x
P/E ratio 2027 * 26.5x
Enterprise value 1.46B 1.26B 1.14B 1.09B 1.99B 135B 2.09B 13.48B 5.4B 64.55B 5.5B 5.38B 231B EV / Sales 2026 *
1.52x
EV / Sales 2027 * 1.26x
Free-Float
99.03%
Yield 2026 *
-
Yield 2027 * -
1 day+0.85%
1 week-2.36%
Current month-2.36%
1 month-4.12%
3 months-56.25%
6 months-24.61%
Current year-31.70%
1 week 60.98
Extreme 60.98
66.5
1 month 53.11
Extreme 53.11
86
Current year 53.11
Extreme 53.11
102.64
1 year 53.11
Extreme 53.11
189.48
3 years 53.11
Extreme 53.11
330
5 years 53.11
Extreme 53.11
330
10 years 22.5
Extreme 22.5
330
Manager TitleAgeSince
Chief Executive Officer 63 31/10/2007
Director of Finance/CFO 50 18/01/2026
Compliance Officer 54 18/01/2021
Director TitleAgeSince
Chairman 63 01/05/2024
Director/Board Member 66 30/06/2008
Director/Board Member 61 31/12/2016
Change 5d. change 1-year change 3-years change Capi.($)
+0.85%-2.36%-65.63%-75.15% 1.8B
-1.60%-5.91%-3.89%+37.26% 140B
-1.63%-4.07%+8.44%+3.36% 14.62B
-3.90%-10.52%+3.40%+126.23% 6.25B
+1.28%-1.48%-18.45%-65.14% 6.15B
+0.15%-7.69%+36.42%+14.50% 2.68B
+1.83%-0.40%-13.32%-22.86% 2.05B
-1.08%+5.79%+16.09%-16.32% 1.88B
+6.40%-10.65%+281.39%+246.85% 1.47B
Average +0.44%-5.48%+27.16%+27.64% 19.6B
Weighted average by Cap. -0.06%-5.84%-0.65%+33.03%

Financials

2026 *2027 *
Net sales 965M 832M 751M 721M 1.31B 88.72B 1.38B 8.88B 3.56B 42.55B 3.62B 3.55B 152B 1.04B 899M 812M 779M 1.42B 95.87B 1.49B 9.6B 3.85B 45.98B 3.92B 3.83B 164B
Net income 49.14M 42.37M 38.25M 36.7M 66.92M 4.52B 70.03M 452M 181M 2.17B 184M 180M 7.75B 70.99M 61.21M 55.25M 53.02M 96.68M 6.52B 101M 653M 262M 3.13B 266M 261M 11.19B
Net Debt -336M -290M -262M -251M -458M -30.9B -479M -3.09B -1.24B -14.82B -1.26B -1.24B -53B -482M -415M -375M -360M -656M -44.29B -687M -4.43B -1.78B -21.24B -1.81B -1.77B -75.95B
Logo Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Employees
1,333
Date Price Change Volume
06/03/26 62.99 $ +0.85% 1,187,316
05/03/26 62.46 $ -2.89% 708,293
04/03/26 64.32 $ -2.25% 758,013
03/03/26 65.80 $ +1.53% 937,483
02/03/26 64.81 $ +0.47% 1,688,815
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
62.99USD
Average target price
77.14USD
Spread / Average Target
+22.47%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW